Patents by Inventor Chiara Nicolo'

Chiara Nicolo' has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9994524
    Abstract: The T cells specific to human collagen type II, one of the possible autoantigens, have a crucial role in the development of rheumatoid arthritis in the context of HLA-DR4. The protein-protein interactions between the T cell receptor (TCR) and the type II collagen linked to the allele MHC of class II HLA-DR4 may thus represent the target for the development of new drugs against rheumatoid arthritis. Using computational virtual screening techniques, families of pharmacologically active molecules have been identified that interfere with the TCR/collagen II-MHCII interaction. The compounds identified here open up new possibilities in the treatment of rheumatoid arthritis.
    Type: Grant
    Filed: March 24, 2017
    Date of Patent: June 12, 2018
    Assignees: CONSIGLIO NAZIONALE DELLE RICERCHE, UNIVERSITÀ CATTOLICA DEL SACRO CUORE
    Inventors: Maria Cristina De Rosa, Francesco Ria, Bruno Giardina, Gianfranco Ferraccioli, Davide Pirolli, Chiara Nicolo′
  • Publication number: 20170204059
    Abstract: The T cells specific to human collagen type II, one of the possible autoantigens, have a crucial role in the development of rheumatoid arthritis in the context of HLA-DR4. The protein-protein interactions between the T cell receptor (TCR) and the type II collagen linked to the allele MHC of class II HLA-DR4 may thus represent the target for the development of new drugs against rheumatoid arthritis. Using computational virtual screening techniques, families of pharmacologically active molecules have been identified that interfere with the TCR/collagen II-MHCII interaction. The compounds identified here open up new possibilities in the treatment of rheumatoid arthritis.
    Type: Application
    Filed: March 24, 2017
    Publication date: July 20, 2017
    Inventors: Maria Cristina DE ROSA, Francesco RIA, Bruno GIARDINA, Gianfranco FERRACCIOLI, Davide PIROLLI, Chiara NICOLO'
  • Patent number: 9630954
    Abstract: The T cells specific to human collagen type II, one of the possible autoantigens, have a crucial role in the development of rheumatoid arthritis in the context of HLA-DR4. The protein-protein interactions between the T cell receptor (TCR) and the type II collagen linked to the allele MHC of class II HLA-DR4 may thus represent the target for the development of new drugs against rheumatoid arthritis. Using computational virtual screening techniques, families of pharmacologically active molecules have been identified that interfere with the TCR/collagen ll-MHCII interaction. The compounds identified here open up new possibilities in the treatment of rheumatoid arthritis.
    Type: Grant
    Filed: April 2, 2013
    Date of Patent: April 25, 2017
    Assignees: Consiglio Nazionale delle Ricerche, Università Cattolica del Sacro Cuore
    Inventors: Maria Cristina De Rosa, Francesco Ria, Bruno Giardina, Gianfranco Ferraccioli, Davide Pirolli, Chiara Nicolo′
  • Publication number: 20150073030
    Abstract: The T cells specific to human collagen type II, one of the possible autoantigens, have a crucial role in the development of rheumatoid arthritis in the context of HLA-DR4. The protein-protein interactions between the T cell receptor (TCR) and the type II collagen linked to the allele MHC of class II HLA-DR4 may thus represent the target for the development of new drugs against rheumatoid arthritis. Using computational virtual screening techniques, families of pharmacologically active molecules have been identified that interfere with the TCR/collagen ll-MHCII interaction. The compounds identified here open up new possibilities in the treatment of rheumatoid arthritis.
    Type: Application
    Filed: April 2, 2013
    Publication date: March 12, 2015
    Inventors: Maria Cristina De Rosa, Francesco Ria, Bruno Giardina, Gianfranco Ferraccioli, Davide Pirolli, Chiara Nicolo'
  • Patent number: 8945738
    Abstract: A device and related method for producing electrical energy, in the form of current flowing in a load. The said method uses two solutions with different ionic concentration as energy source. The said device includes at least two electrodes immersed at least partially in a liquid contained in a cell. The method includes a plurality of phases. Among them, a phase in which the electrodes and are brought into contact with a first solution; a phase in which they are electrically charged; a phase in which they are brought into contact with a second solution; a phase in which at least a part of the accumulated charge is let flow through the load. The energy provided to the load is more than the energy used to charge the electrodes.
    Type: Grant
    Filed: March 11, 2010
    Date of Patent: February 3, 2015
    Assignee: Redstack B.V.
    Inventors: Doriano Costantino Brogioli, Maria Chiara Nicolo
  • Publication number: 20120052338
    Abstract: A device and related method for producing electrical energy, in the form of current flowing in a load. The said method uses two solutions with different ionic concentration as energy source. The said device includes at least two electrodes immersed at least partially in a liquid contained in a cell. The method includes a plurality of phases. Among them, a phase in which the electrodes and are brought into contact with a first solution; a phase in which they are electrically charged; a phase in which they are brought into contact with a second solution; a phase in which at least a part of the accumulated charge is let flow through the load. The energy provided to the load is more than the energy used to charge the electrodes.
    Type: Application
    Filed: March 11, 2010
    Publication date: March 1, 2012
    Inventors: Doriano Costantino Brogioli, Maria Chiara Nicolo